1. Switzerland Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Sonova Holding AG

Sonova Holding AG

0QPY.IL
Sonova Holding AGGB flagInternational Order Book
243.60
CHF
+4.10
- -
14.47BMarket Cap
Sonova Holding AG
0QPY.IL
(International Order Book)

Recent

price

243.60

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
FRC
121.56
121.02
133.76
28.88
30.14
31.21
36.43
40.24
42.19
45.62
41.32
54.02
62.07
60.82
60.62
- -
Revenue per Share
17.37
18.44
8.18
5.04
5.33
5.08
5.31
6.08
6.93
7.56
9.23
10.42
10.75
10.08
9.07
- -
Basic EPS, GAAP
17.52
16.75
22.71
4.68
5.49
5.2
6.45
7.96
8.14
11.18
10.72
13.4
10.45
10.48
11.05
- -
Free Cash Flow per Basic Share
5.97
5.97
5.95
1.59
1.89
2.05
2.09
2.29
2.59
2.92
- -
3.24
4.44
4.6
4.3
- -
Dividend per Share
20.02
22.08
23.87
25.81
27.5
28.58
32.02
37.28
36.33
32
43.59
39.46
37.12
41.44
44.7
44
Book Value per Share
4.19
5.35
6.11
8.63
9.32
8.09
-3.26
-0.22
-1.69
-6.51
5.17
-8.81
-14.19
-9.53
-5.37
-0.12
Tangible Book Value per Share
13
13
13
68
68
66
66
66
66
64
63
62
60
60
60
- -
Basic Weighted Avg Shares
1,617
1,620
1,795
1,951
2,035
2,072
2,396
2,646
2,763
2,917
2,602
3,364
3,738
3,627
3,613
3,606
Sales/Revenue/Turnover
18.95
18.22
8.66
20.71
21.08
19.05
17.69
18.05
19.39
17.48
19.03
22.6
19.98
18.47
19.92
18.74
Operating Margin (%)
103
78
82
83
85
89
147
135
128
200
223
211
240
246
233
260
Depreciation Expense
231
247
110
341
360
337
349
400
454
483
581
649
648
601
540
431
Net Income, GAAP
11.16
12.55
25.32
11.96
12.37
12.9
14.65
14.93
13.1
2.57
2.53
8.86
8.02
5.84
17.45
14.91
Effective Tax Rate (%)
14.29
15.23
6.11
17.47
17.69
16.27
14.58
15.12
16.43
16.57
22.33
19.29
17.32
16.57
14.96
11.94
Profit Margin (%)
278
341
615
507
569
499
532
582
282
118
1,368
154
409
514
411
895
Working Capital
228
242
229
- -
- -
- -
759
609
360
767
1,410
1,080
1,736
1,715
1,328
1,525
LT Debt
1,345
1,481
1,641
1,774
1,872
1,906
2,131
2,475
2,376
2,029
2,772
2,433
2,231
2,491
2,685
2,636
Total Equity
15.77
14.84
6.26
18.75
19.59
17.53
14.58
12.85
14.48
15.83
12.23
15.81
16.65
14.57
13.11
12.73
Return on Invested Capital (%)
13.82
15.06
6.26
18.31
19.01
17.44
14.33
12.88
14.47
15.92
15.44
15.35
16.53
14.86
12.74
10.15
Return on Capital (%)
17.79
17.51
7.1
20.3
20.06
18.09
17.5
17.55
18.9
22.14
24.42
25.16
28.01
25.67
21.05
16.32
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
4.3%
-0.59%
-1.81%
Free Cash Flow
7.62%
-0.08%
-4.07%
Net Income, GAAP
3.22%
-5.22%
-20.33%
Sales/Revenue/Turnover
6.21%
7.37%
-0.19%
Total Cash Common Dividend
10,066.44%
20,146.2%
2.38%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
3,627
2025
- -
- -
- -
- -
3,613
2026
- -
- -
- -
- -
3,606

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
10.08
2025
- -
- -
- -
- -
9.07
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
4.6
2025
- -
- -
- -
- -
4.3
2026
- -
- -
- -
- -
- -
Similar Companies
Xiangyu Medical Co.,Ltd (688626.SS)
Rion Co., Ltd. (6823.T)
Mobia Medical, Inc. Common Stock (MOBI)
ACRO Biomedical Co., Ltd. (6748.TWO)
Sonova Holding AG (0QPY.IL)
Contec Medical Systems Co.,Ltd (300869.SZ)
Business
Sonova Holding AG, a leading provider of innovative hearing care solutions, engages in the design, manufacture, distribution, and sale of hearing instruments and related services. Main products and services include hearing aids across disposable, reusable, and premium lines; cochlear implant systems; bone-anchored and wireless accessories; hearing protection and patient care devices; professional diagnostic and fitting software; and aftercare services such as fitting, repairs, and remote care solutions. The company operates through core brands and product families in hearing health, with professional channels serving audiology clinics, hearing care professionals, and end customers. Latest major company changes include strategic partnerships and alliances in audiology technology, expansion of direct-to-consumer and professional channels, acquisitions and investments in innovative hearing solutions and related accessories, and launches of new product generations and software platforms. The company reports recent reorganizations and operational enhancements to support global distribution, R&D, and digital health initiatives, along with geographic expansion activities. Industry and business segments focus on hearing care and optically linked health technologies with geographic operations spanning Europe, North America, Asia-Pacific, and other regions. Founding year is 1946 with headquarters in Staefa-Zh, Switzerland. Sonova maintains subsidiaries and brand-level operations worldwide, including affiliated entities within its global corporate structure. The company emphasizes advanced audiology products, patient-centered care, and scalable hearing care solutions for diverse customer groups, including individual consumers, clinics, and healthcare providers.